Type 2 Diabetes (Insulin Resistance & Metabolic Disfunction)
About This Condition
Type 2 diabetes is a chronic metabolic disorder characterized by elevated blood glucose resulting from progressive insulin resistance and eventual pancreatic beta-cell dysfunction. It affects over 37 million Americans, with tens of millions more in a pre-diabetic state. Standard care focuses almost exclusively on glycemic control — lowering HbA1c via medication — without addressing the underlying metabolic dysfunction. The result: patients stay on escalating drug regimens while the disease continues to progress. Common comorbidities include hypertension, dyslipidemia, nonalcoholic fatty liver disease, peripheral neuropathy, and increased cardiovascular risk.
.svg)
.png){kind=logo}
